Showing results (1491-1500 of 1,514) with videos related to

Sort By:
Pageof 152
Nature Methods|August 5, 2008
eSGA: E. coli synthetic genetic array analysisGareth Butland, Mohan Babu, J Javier Díaz-Mejía, et al.
Cell Reports|July 9, 2024
The TSC22D, WNK, and NRBP gene families exhibit functional buffering and evolved with Metazoa for cell volume regulationYu-Xi Xiao, Seon Yong Lee, Magali Aguilera-Uribe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 23, 2023
Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindredJesse Nicholas Cochran, Juliana Acosta-Uribe, Bianca T Esposito, et al.
IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing|July 2, 2021
Microwave Radiometry at Frequencies From 500 to 1400 MHz: An Emerging Technology for Earth ObservationsJoel T Johnson, Kenneth C Jezek, Giovanni Macelloni, et al.
Vaccine|June 17, 2022
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platformJemma L Walker, Anna Schultze, John Tazare, et al.
Lancet (London, England)|August 9, 2021
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trialXinxue Liu, Robert H Shaw, Arabella S V Stuart, et al.
Science (New York, N.Y.)|November 5, 2016
Exploring genetic suppression interactions on a global scaleJolanda van Leeuwen, Carles Pons, Joseph C Mellor, et al.
Molecular Cell|October 3, 2025
A needed nomenclature for nucleosomesMichael-Christopher Keogh, Genevieve Almouzni, Andrew J Andrews, et al.
The Lancet. Respiratory Medicine|June 11, 2022
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trialRobert H Shaw, Xinxue Liu, Arabella S V Stuart, et al.
The Journal of Infection|April 7, 2023
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccinesRobert H Shaw, Melanie Greenland, Arabella S V Stuart, et al.
Pageof 152